Plant Viruses as Nanoparticle-Based Vaccines and Adjuvants. - RIIP - Réseau International des Instituts Pasteur Access content directly
Journal Articles Vaccines Year : 2016

Plant Viruses as Nanoparticle-Based Vaccines and Adjuvants.


Vaccines are considered one of the greatest medical achievements in the battle against infectious diseases. However, the intractability of various diseases such as hepatitis C, HIV/AIDS, malaria, tuberculosis, and cancer poses persistent hurdles given that traditional vaccine-development methods have proven to be ineffective; as such, these challenges have driven the emergence of novel vaccine design approaches. In this regard, much effort has been put into the development of new safe adjuvants and vaccine platforms. Of particular interest, the utilization of plant virus-like nanoparticles and recombinant plant viruses has gained increasing significance as an effective tool in the development of novel vaccines against infectious diseases and cancer. The present review summarizes recent advances in the use of plant viruses as nanoparticle-based vaccines and adjuvants and their mechanism of action. Harnessing plant-virus immunogenic properties will enable the design of novel, safe, and efficacious prophylactic and therapeutic vaccines against disease.
Fichier principal
Vignette du fichier
vaccines-03-00620.pdf (227.04 Ko) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

pasteur-01352188 , version 1 (05-08-2016)





Marie-Ève Lebel, Karine Chartrand, Denis Leclerc, Alain Lamarre. Plant Viruses as Nanoparticle-Based Vaccines and Adjuvants.. Vaccines, 2016, 3 (3), pp.620-37. ⟨10.3390/vaccines3030620⟩. ⟨pasteur-01352188⟩


85 View
142 Download



Gmail Facebook X LinkedIn More